Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma (Q44609910)
Jump to navigation
Jump to search
scientific article published in October 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma |
scientific article published in October 2003 |
Statements
1 reference
Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma (English)
1 reference
1 reference
S Vincent Rajkumar
1 reference
John A Lust
1 reference
Shaji Kumar
1 reference
Michael A Thompson
1 reference
Thomas E Witzig
1 reference
Michael M Timm
1 reference
Jessica Haug
1 reference
Philip R Greipp
1 reference
1 October 2003
1 reference
1 reference
123
1 reference
2
1 reference
305-308
1 reference
Identifiers
1 reference
1 reference